Search

AxoGen Inc

Closed

SectorHealthcare

41.79 -0.14

Overview

Share price change

24h

Current

Min

41.61

Max

42.51

Key metrics

By Trading Economics

Income

18M

-1.5M

Sales

8.3M

70M

EPS

-0.03

Profit margin

-2.174

Employees

622

EBITDA

15M

-2.2M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+30.16% upside

Dividends

By Acuity

Next Earnings

28 paź 2026

Market Stats

By TradingEconomics

Market Cap

408M

2.6B

Previous open

41.93

Previous close

41.79

News Sentiment

By Acuity

50%

50%

126 / 339 Ranking in Healthcare

AxoGen Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

11 wrz 2026, 20:13 UTC

AxoGen Inc shares are lower in after-market hours with no specific news identified. Recent inflation data has raised speculation about a Federal Reserve rate hike.

10 wrz 2026, 20:03 UTC

News
Social Media
Event

AxoGen Inc shares are lower after announcing a public offering of 4.91 million shares at $42.50 to fund its $200 million acquisition of BioCircuit Technologies.

8 wrz 2026, 20:07 UTC

News

AxoGen Inc shares are lower today, continuing a downward trend amid speculation of an interest rate hike following a stronger-than-expected jobs report.

3 wrz 2026, 19:56 UTC

AxoGen Inc shares are lower, extending a five-session decline amid broader market dynamics and a drop in Treasury yields following jobless claims data.

2 wrz 2026, 20:01 UTC

AxoGen Inc shares are lower today, marking four consecutive sessions of declines. Broader market sentiment is affected by a disappointing ADP employment report.

1 wrz 2026, 20:09 UTC

News

AxoGen Inc shares are lower today, continuing a decline since Monday amid rising oil prices and inflation concerns affecting the health care equipment sector.

31 sie 2026, 21:01 UTC

AxoGen Inc shares are higher in after-market trading, reflecting positive momentum despite no specific company news. Broader market sentiment is influenced by Fed Chair Warsh's remarks.

28 sie 2026, 23:01 UTC

AxoGen Inc shares are higher in after-market trading, reflecting positive momentum. The stock is near the upper end of its one-month trading range.

27 sie 2026, 19:56 UTC

News

AxoGen shares are higher as Bamco Inc. acquired 740,210 shares valued at $34.19 million in the second quarter, boosting institutional sentiment.

26 sie 2026, 23:01 UTC

AxoGen Inc shares are higher in after-market trading, reflecting broader market trends and positive macroeconomic data indicating underlying economic strength.

25 sie 2026, 19:46 UTC

AxoGen Inc shares are higher during Tuesday's session, reflecting upward momentum amid broader positive trends in equities and a favorable health care equipment sector.

24 sie 2026, 21:01 UTC

AxoGen Inc shares are higher in after-market trading, maintaining gains since Monday's close and positioned near the upper end of their one-month range.

21 sie 2026, 20:01 UTC

AxoGen Inc shares are higher today, supported by high trading volume. The stock remains above its 20-day moving average amid broader market gains.

20 sie 2026, 22:46 UTC

AxoGen Inc shares are higher in after-market trading, showing notable strength above the 20-day moving average and near the upper end of its one-month range.

19 sie 2026, 21:01 UTC

AxoGen Inc shares are lower in after-market trading, despite no specific news to explain the decline. The stock remains near its one-month high.

18 sie 2026, 19:16 UTC

AxoGen Inc shares are higher, continuing positive momentum from Monday. The stock remains above its 20-day moving average, reflecting strong performance.

17 sie 2026, 21:01 UTC

AxoGen Inc shares are higher in after-market trading, reaching a peak above Monday's close amid broader market pressures and rising crude oil prices.

14 sie 2026, 20:06 UTC

AxoGen Inc's shares are higher today amid mixed market sentiment following a decline in U.S. retail sales for July. No specific company news was identified.

13 sie 2026, 22:36 UTC

AxoGen Inc. shares declined in after-market trading, despite broader market strength and earlier gains. The stock remains above recent performance averages.

12 sie 2026, 19:32 UTC

AxoGen Inc shares are higher today amid strong trading volume and broader market gains, reflecting optimism from recent inflation data.

10 sie 2026, 19:41 UTC

AxoGen Inc shares are higher, driven by gains in the Health Care Equipment sub-sector and unusually high market volume. The stock remains above its 20-day moving average.

7 sie 2026, 20:05 UTC

AxoGen Inc shares are higher today amid strong market volume, reflecting a broader upward trend since Thursday's close.

5 sie 2026, 19:46 UTC

AxoGen Inc shares are lower amid broader market caution following ADP's report of a significant miss in private sector job growth for July.

4 sie 2026, 20:06 UTC

AxoGen Inc's shares are higher today, continuing a steady climb since Monday's close amid positive market sentiment and broader trends.

3 sie 2026, 20:02 UTC

News

AxoGen Inc. shares are advancing as trading volume spikes amid strong interest. The company reported a 23.1% revenue increase to $69.7 million for Q2 2026.

31 lip 2026, 20:06 UTC

AxoGen Inc shares are higher, recovering from an earlier dip. The stock remains above its 20-day moving average, reflecting solid overall performance.

30 lip 2026, 19:24 UTC

AxoGen Inc shares are higher, supported by significant broader market gains and unusually high trading volume, despite earlier pulling back from session highs.

29 lip 2026, 20:41 UTC

AxoGen Inc shares are lower in after-market trading amid a broader downturn in U.S. equities and rising crude oil prices linked to geopolitical tensions.

28 lip 2026, 20:03 UTC

AxoGen Inc. shares are declining today, pulling back from an earlier high amid broader market weakness linked to declines in Asian indices.

27 lip 2026, 19:16 UTC

AxoGen Inc shares are higher today, continuing a strong upward trend since Friday's close. Broader market sentiment is influenced by declining oil prices.

Peer Comparison

Price change

AxoGen Inc Forecast

Price Target

By TipRanks

30.16% upside

12 Months Forecast

Average 54.875 USD  30.16%

High 60 USD

Low 48 USD

Based on 8 Wall Street analysts offering 12 month price targets forAxoGen Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

8 ratings

8

Buy

0

Hold

0

Sell

Sentiment

By Acuity

126 / 339 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About AxoGen Inc

Axogen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. Axogen, Inc. is headquartered in Alachua, Florida.
help-icon Live chat